Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hundreds Of Privately Created Stem Cell Lines Could Become Available To Researchers Under NIH Proposal

This article was originally published in The Pink Sheet Daily

Executive Summary

Draft NIH stem cell guidelines would allow funding for research with lines created under similar guidance during the ban, including lines with disease mutations.

You may also be interested in...



Expanded NIH Stem Cell Support Means Novel Drug Development Tools

A new generation of specialized drug development tools based on human embryonic stem cells - and maybe down the road new regenerative therapies - got a boost with the release of the Obama administration's hESC research guidelines July 6

Expanded NIH Stem Cell Support Means Novel Drug Development Tools

A new generation of specialized drug development tools based on human embryonic stem cells - and maybe down the road new regenerative therapies - got a boost with the release of the Obama administration's hESC research guidelines July 6

NIH’s Stem Cell Guidelines To Get Dusted Off After Obama Lifts Ban

Academic researchers will benefit from access to federal funding, while benefits to industry may be less immediate.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS069294

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel